Linc AB

LINC · Nasdaq Stockholm · Financial services

67.60SEK −0.9%last day

Price as of 2 October 2026

The price over the past year, with dividends: −4.7%

Performance

1 month

−8.8%

1 year

−4.7%

3 years, per year

+3.7%

5 years, per year

−3.9%

Largest fall, 3 years

−54.1%

Below the peak now

−41.2%

Volatility, 1 year

27.1%

Return with dividends reinvested.

Key figures

P/E

11.6

P/B

0.8

Dividend yield

0.0%

Return on equity

+7.2%

Net margin

+112.2%

Market value

389 m USD

Quality, value and trend

Where Linc stands against every Nordic stock today. 100 is best.

Quality79

Profitability and a sound balance sheet over time. Better than 79% of Nordic stocks.

Value59

The price measured against earnings, assets and cash flow. Better than 59% of Nordic stocks.

Trend44

The price development over the past year. Better than 44% of Nordic stocks.

Combined69

Quality, value and trend together. Better than 69% of Nordic stocks.

About Linc

Linc AB is a company in financial services, listed on Nasdaq Stockholm. The share trades in SEK. It has around 2 employees.

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.99 million), the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis